Select country change
Shopping cart (0 , 0,00 ) Menu Search

Scientific References

BioVendor collects scientific publications where the use of our immunoassays, recombinant proteins, and monoclonal and polyclonal antibodies is cited.

Filter references:
  • References to Hepatitis B Protein X (HBx) Virus Human, Rabbit Polyclonal Antibody

    • Kim W, Lee S, Son Y, Ko C, Ryu WS. DDB1 stimulates the viral transcription of hepatitis B virus via HBx-independent mechanisms. J Virol. 2016 Aug 17;
  • References to HIV-1 Protease E.coli

    • Ingr M, Uhlikova T, Strisovsky K, Majerova E, Konvalinka J. Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization. Protein Sci. 2003 Oct;12 (10):2173-82
    • Lindsten K, Uhlikova T, Konvalinka J, Masucci MG, Dantuma NP. Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity. Antimicrob Agents Chemother. 2001 Sep;45 (9):2616-22
    • Parra A, Martin-Fonseca S, Rivas F, Reyes-Zurita FJ, Medina-O'Donnell M, Martinez A, Garcia-Granados A, Lupianez JA, Albericio F. Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents. Eur J Med Chem. 2014 Mar 3;74:278-301
    • Saskova KG, Kozisek M, Rezacova P, Brynda J, Yashina T, Kagan RM, Konvalinka J. Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir. J Virol. 2009 Sep;83 (17):8810-8
  • References to Homoarginine ELISA

    • A. Meinitzer, Ch Drechsler. A. Tomaschitz, S. Pilz, V. Krane, Ch. Wanner, W. März Homoarginin, ein neuer kardiovaskulärer Risikomarker bei Dialysepatienten J. Lab. Med. 2011, 35 (3): 153 -159, copy 2011 by Walter de Gruyter, Berlin, Boston
    • A. Jazwinska-Kozuba, J. Martens-Lobenhoffer, O. Kruszelnicka, J. Rycaj, B. Chyrchel, A. Surdacki, S. M. Bode-Böger Opposite Associations of Plasma Homoarginine and Ornithine with Arginine in Healthy Children and Adolescents Int. J. Mol. Sci. 2013, 14, 21819-21832
    • A.A. Khalil, D. Tsikas, R. Akolekar, J. Jordan, K.H. Nicolaides Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks´ gestation and preeclampsia: a case control study. J. of Human Hypertension January 2013 27; 38-43
    • Ch. Drechsel, B. Kolleritz. A, Meinitzer, W. März, E. Ritz, P. König, U. Neyer, S. Pilz, Ch. Wanner, F. Kronenberg Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study May 2013; Plos One, 10, 1371
    • Choe CU, Atzler D, Wild PS, Carter AM, Böger RH, Ojeda F, Simova O, Stockebrand M, Lackner K, Nabuurs C, Marescau B, Streichert T, Müller C, Lüneburg N, De Deyn PP, Benndorf RA, Baldus S, Gerloff C, Blankenberg S, Heerschap A, Grant PJ, Magnus T, Zeller T, Isbrandt D, Schwedhelm E Homoarginine levels are regulated by L-arginine: glycine amidinotransferase and affect stroke outcome; results from human and murine studies Circulation, 2013 Sep 24, 128 (13) 1451-1461
    • Pietro Ravani, Renke Maas, Fabio Malberti, Paola Pecchini, Maren Mieth, Robert Quinn, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients Plos One; September 2013, Volume 8, Issue 9: 1-6
    • van der Zwan, L., Davids, M., Scheffer, P.; et al. L-Homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study Journal of Hypertension 2013: 31:1114–112
    • W. März A. Meinitzer, Ch. Drechsler, S. Pilz, V. Krane, M.E. Kleber, J. Fischer, B.R. Winkelmann, B.O. Böhm, E. Ritz, Ch. Wanner. Homoarginine, Cardiovascular Risk and Mortality Circulation 2010, 122: 967-975
  • References to hsCRP Canine ELISA

    • Burton, S.A., et. al. C-reactive protein concentration in dogs with inflammatory leukograms. Am. J.Vet. Res. 1994; 55:613 – 618.
    • Casals, C. et. al. Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am. J. Respir. Crit. Care. Med. 1998; 157: 43 – 49.
    • Conner, J.G., et. al. Acute phase response in the dog following surgical trauma. Res. Vet. Sci. 1988; 45: 107 – 110.
    • Eckersall, P.D. et. al., An immunoturbidimetric assay for canine C-reactive protein. Vet. Res. Commun. 1991; 15: 17 – 24.
    • Lindback, S., et. al. The value of C-reactive protein as a marker of bacterial infection in patients with septicemia, endocarditis, and influenza. Scand. J. Infect. Dis. 1989; 21: 543 – 549.
    • Ndung’u, J.M. et. al. Elevation of the concentration of acute phase proteins in dogs infected with Trypanosoma brucei. Acta. Trop. 1991;49: 77 – 86.
    • Otabe, K. Physiological levels of C-reactive protein in normal canine sera. Vet. Res. Commun. 1998; 22: 77 – 85.
    • Rikihisa, Y. et. al. C-reactive protein and alpha1-acid glycoprotein levels in dogs infected with Ehrlichia canis. J. Clin. Microbiol. 1994; 32: 912 – 917.
    • Yamamoto, S. et. al. Determination of C-reactive protein in serum and plasma from healthy dogs and dogs with pneumonia by ELISA and slide reversed passive latex agglutination test. Vet. Q. 1994; 16: 74 – 77.
    • Yamashita,K., et.al. Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs. J. Vet. Med. Sci. 1994; 56: 487 – 492.
  • References to hsCRP Human ELISA

    • Gkalpakiotis S, Arenbergerova M, Gkalpakioti P, Potockova J, Arenberger P, Kraml P. Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study. J Dermatol. 2016 Oct 24;
    • Hussein NA, Mahmoud OM, Zahran MY, Rafaat MA. Serum Fetuin-A in Chronic Renal Disease Patients: Contribution to Endothelial Dysfunction and Hemostatic alteration. Journal of American Science. 2010;6(12);
    • Mostafa S, Obaia M, Mahmoud Abd El Aziz G, Fathi M, Iaz N. Surfactant Protein D and C-Reactive Protein as serum biomarkers in Chronic Obstructive Pulmonary D. Bull. Egypt. Soc. Physiol. Sci. 2011;31 (1):179-193
    • Salas-Perez F, Codner E, Valencia E, Pizarro C, Carrasco E, Perez-Bravo F. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes. Immunobiology. 2013 May;218 (5):733-7